Bio Briefs

Posted By

Flinn Foundation

Research-icon-large

TGen and TD2 help Critical Outcome Technologies to present data at US Oncology summit

Tags: cancer, tgen

[Source: TGen] - Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) is pleased to announce that it has accepted an invitation from US Oncology to present at the US Oncology Translational Oncology Program (TOP) Science Summit in Houston, Texas, on March 27, 2010.

The TOP science summit is a collaborative forum of scientific and academic thought leaders in early phase oncology research who assemble at this annual event to discuss new trends in oncology drug development and learn about promising investigational cancer compounds entering development.

For more information: TGen and TD2 help Critical Outcome Technologies to present data about COTI-2 at US Oncology summit in Texas